Mendaera brings in $24M for medical platform

Listen to this article

Mendaera, Inc, a company developing a collaborative robotic system for healthcare providers, has brought in $24 million in Series A funding. The company recently completed the research and design for its robotic system and is now focused on completing deployment and obtaining FDA clearance. 

The company also announced its expansion into a production facility to further support future growth and operations. The Silicon Valley-based facility will allow Mendaera to grow rapidly and increase volume manufacturing for product launch. 

Mendaera’s platform aims to give healthcare providers the tools they need to do more for patients. It combines real-time imaging, robotics, and artificial intelligence (AI) to facilitate precise and consistent intervention. 

Along with its platform, Mendaera is working to build an ecosystem of industry-leading imaging and instrumentation partners to expedite its mission to democratize minimally invasive care. 

“Despite the impact that robotics has already made in healthcare, our team has worked diligently to develop a new category of robotic technology that will streamline patient care,” Josh DeFonzo, co-founder and CEO of Mendaera, Inc, said. “We believe there is an opportunity to push the category further and dramatically improve access to intervention.”

Lux Capital led Mendaera’s funding round, which also included participation from the Founders Fund, Operator Partners, and Allen & Company. Other investors in the round included Intuitive Surgical, Dr. Fred Moll, founder of Auris Health, and former US Senator Bob Kerrey. 

“This is an incredibly exciting time for robotics in healthcare,” Dr. Fred Moll said. “Among the innovators in the field, Mendaera’s efforts to make robotics commonplace earlier in the healthcare continuum are unique and can potentially change the future of care delivery.”

“The most talented entrepreneurs – armed with truly unique technology – can create magical products,” Peter Hebert, co-founder and managing partner of Lux Capital, said. “Fred and I had the distinct pleasure of working closely with Josh DeFonzo at Auris Health, and strongly believe that he will again build a generational healthcare company to transform provider workflows and patients’ lives.”